Cord Blood America Inc. CBAI Archives - Page 3 of 4

MondayMay 14, 2007 5:02 am

Cord Blood America, Inc (CBAI.OB) Pays off Debt Six Months Ahead of Schedule

Cord Blood and its loaner, Bergen Community Regional Blood Centers, reached an agreement to cancel a quarter million dollar of debt, plus its interest. In only six payments, the company paid off the entire debt using cash flow and money from private investors. Matthew Schissler, CEO of Cord Blood, commented that the agreement will allow Cord Blood to have additional funds, and also affirms the company’s financial soundness. He plans to retire more debt, and begin growing the company through "intelligent, organic growth, accretive acquisitions, pushing towards being cash flow positive and de-levering the balance sheet." Let us hear your thoughts…

ThursdayMay 10, 2007 6:45 am

Clearing Debt and Positive Growth – Two Top Priorities for Cord Blood America, Inc. (CBAI.OB) in 2007

Cord Blood America, Inc. (CBAI.OB), reports that the Company is moving closer to eliminating its registered debt. CEO Matthew Schissler noted that "Debt helped this Company grow and grow quickly, but we believe our stock price is languishing because of the debt". CBAI feels that it is close to eliminating the registered debt altogether. Clearing the debt along with positive growth are the two top priorities of CBAI in 2007. Let us hear your thoughts below:

ThursdayMay 10, 2007 4:15 am

Cord Blood America, Inc. (CBAI.OB) Reveals They are Completing the Elimination of Registered Debt

Yesterday, Cord Blood America revealed on the National Business Radio Show 'Your Monies Worth', that they are nearing completion of eliminating debt. The CEO, Matthew Schissler, commented that the debt has helped the company grow rapidly, but he has concerns that the stock price is effected by the debt. Clearing Debt and Growing Positively were two main priorities for Cord Blood America this year, and the CEO believes that the company has been executing both plans well. From 2005 to 2006, revenues grew 71%. Mr. Schissler summed his company’s growth, “The Company, going forward, is focused on strategic accretive acquisitions,…

TuesdayMay 08, 2007 8:20 am

The CEO of Cord Blood America, Inc. (CBAI.OB) Will Take to the Airwaves Wednesday May 9th, Featured on the National Business Radio Program; “Your Monies Worth”

Cord Blood America, Inc. (CBAI.OB) reports that its CEO Mr. Matthew Schissler will be interviewed by longtime talk show host and broadcaster Mick "Mixter" Bazsuly on the National Business Radio Show "Your Monies Worth" on the Beasley Broadcasting Network. The show will air at approximately 7:15 p.m. Eastern, 4:15 p.m. Pacific on Wednesday, May 9th. The interview can be heard online at http://www.fortunemarket.net and http://www.wsbrradio.com, as well as on 740 AM in South Florida. Mr. Schissler will be interviewed about umbilical cord blood stem cell collection, the stem cell sector, and its future impact on America's health, said Kathleen Bazsuly, producer…

TuesdayMay 08, 2007 7:23 am

Cord Blood America, Inc. (CBAI.OB) Will Take the Spot Light on a National Radio Show Later This Month

Matthew Schissler, CEO of Cord Blood America, will be featured in an interview on "Your Monies Worth", broadcasted by the Beasley Broadcasting Network, at 7:15 P.M. EST on May 9th. The longtime talk show host and broadcaster Mick 'Mixter' Bazsuly will be conducting the interview. Topics discussed will include umbilical cord blood stem-cell collection, the stem cell sector, and its future impact on America's health. Let us hear your thoughts below:

FridayMay 04, 2007 4:10 am

Buyins.net Research Report Calculates Cord Blood America, Inc. (CBAI.OB) Squeeze Trigger Price at $0.28

Cord Blood America, Inc. (CBAI.OB) reports that Buyins.net recently released a research report reflecting trading data on the Company. From June 2005 to April 2007 approximately 129.2 million total aggregate shares of CBAI were traded for a total dollar value of nearly $36.6 million. The total aggregate number of shares shorted in this time period was approximately 9.9 million shares. The CBAI SqueezeTrigger price of $0.28 is the volume weighted average short price of all short selling in CBAI. The first of several short squeezes is expected to begin when shares of CBAI close above $.09 per share, where over 173,000 shares have…

FridayMay 04, 2007 3:55 am

Buyins.Net Reported Cord Blood America, Inc. (CBAI.OB) Has Traded 129.2 Million Shares Since June 2005

From June 2005 to this April, 129.2 million total aggregate shares have traded totaling to a dollar value of nearly $36.6 Million. Almost 10 million of those shares were shorted, averaging at the price of $0.28. Buyins.net expects a big short squeeze to initiate at $0.28, which will drive prices up rapidly. A preliminary short squeeze is expected to occur at $0.09, where more than 173,000 shares were shorted. Let us hear your thoughts below:

ThursdayMay 03, 2007 4:33 am

Newly Appointed Chairman of Medical Advisory Board at Cord Blood America, Inc. (CBAI.OB) Reports First Cord Blood Transplant for Childhood Leukemia

Cord Blood America, Inc. (CBAI.OB), the umbilical cord blood banking company, reports that it has named Jack Goldberg, M.D., as Chairman of its Medical Advisory Board. Dr. Goldberg served as medical director at CorCell, which is now a Cord Blood America subsidiary, since 1996. He also serves as the Chief of the Division of Hematology and Oncology at Penn Presbyterian Medical Center, University of Pennsylvania Health System. Dr. Goldberg recently announced for Cord Blood America, the first known worldwide report of a girl with leukemia who was successfully transplanted with her own umbilical cord blood, which had been stored by CorCell.…

ThursdayMay 03, 2007 4:33 am

Cord Blood America, Inc. (CBAI.OB) Adds Medical Director to Advisory Board

Cord Blood America announced today that Jack Goldberg, M.D. will serve as the Chairman of its Medical Advisory Board. Dr. Goldberg served as a medical director previously at CoreCell, which is now a subsidiary of Cord Blood America. He also serves as Chief of the Division of Hematology and Oncology at Penn Presbyterian Medical Center, University of Pennsylvania Health System. Dr. Goldberg has an impressive resume. His primary accomplishment is being the first doctor to report that he had successfully transplanted a patient’s umbilical cord blood into her own blood stream. He also appeared on “Good Morning America” to discuss…

WednesdayApr 18, 2007 4:12 am

Revenues Soar at Cord Blood America Inc.(CBAI.OB), as Company Sees Revenue Gain of 71 Percent in 2006

Cord Blood America, Inc. (CBAI.OB), the umbilical cord blood stem cell preservation company, reports revenues for 2006 topped $3.89 million, up 71 percent compared to revenues of $2.28 million in 2005. The Company posted a gross profit of $703,933 in 2006, up 37 percent compared to $513,340 in the previous year. The loss from operations decreased significantly in 2006, as the company recorded a $2. 1 million interest expense, more than 35% of the loss. "The results we are posting, we believe, will be recognized as a significant achievement by both the financial markets and by investors," said Matthew Schissler, CEO.…

Site Search

Company Search

Tag: Cord Blood America Inc. CBAI